Tigenix buys CoreTheraphics
TiGenix a leading European cell therapy company with a strong platform of clinical-stage adult stem cell programmes and a marketed product, has acquired Spanish company Coretherapix, belonging to Genetrix and dedicated to the development of cardiac cell therapies.
The purchase allows Tigenix to enter new markets with a cardiac stem cell platform that could be developed for other heart diseases.
"In 2013 Grifols bought a 21.3% stake in Tigenix becoming its largest shareholder and is currently considering listing Tigenix on the US stock exchange," says Diego Gutierrez of Grifols. Abra-Invest.
Ekuore receives support from Europe
The company eKuoreone of the winning projects of Lanzadera, has received 50,000 euros of investment in the Horizon 2020 Programme. for the launch of its eKuore Pro medical stethoscope.
eKuore Pro, which will be launched in the last quarter of 2015, is the first stethoscope capable of transmitting auscultation to smartphones, tablets and audio equipment, and also measures beats per minute, records auscultation and filters the sound of the heart or lungs, with entirely Spanish technology.
The funding obtained is focused on feasibility studies, competitor studies, new business models, marketing, risk analysis and intellectual property studies.
Bayer brings Grants4Apps® initiative to Spain to support innovative healthcare startups
After three successful years in Berlin, the programme Grants4Apps arrives in Spain through Grants4Apps Coworking Barcelona, an initiative aimed at startups with innovative e-health projects - from applications to medical devices, including software or hardware - that contribute to the improvement of health and/or pharmaceutical processes.
The programme offers five startups a workspace in the offices of Bayer in Sant Joan Despí (Barcelona) for six months (from October to March) free of charge, with an office for each selected team and meeting rooms. The aim of this initiative is to support entrepreneurship and innovation in digital health by promoting and supporting projects aimed at health professionals and patients.
In addition, the programme offers mentoring and coaching The Bayer Group's experts and external specialists will provide personalised advice and support, networkingThe G4A Chillout Networking area, contact with potential investors and a 'G4A Chillout Networking' area to enhance communication between the startups and Bayer employees.
Other posts that may interest you
Biotechnology finds a new form of funding with Crowdfunding and Spain is one of the pioneers
Biotechnology grows and finds alternative forms of financing
EN 
ES